Abiopharma

🔍 Kocher Brian W (Director)

Company: SunOpta Inc. (STKL)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 213,211 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Sold 84,000 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 141,007 shares of Restricted Stock Unit (RSU) (Derivative)
  Date: 2026-05-01 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F3
• Sold 676,595 shares of Performance Stock Units (Derivative)
  Date: 2026-05-01 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F5, F5, F5
• Sold 230,804 shares of Stock Option (right to buy Common Stock) at $5.54 per share (Derivative)
  Date: 2026-05-01 | Code: D | Expires: 2034-01-02 | Exercise: 2025-01-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6
• Sold 216,660 shares of Stock Option (right to buy Common Stock) at $3.92 per share (Derivative)
  Date: 2026-05-01 | Code: D | Expires: 2035-04-11 | Exercise: 2026-04-11 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6

Footnotes:

• F1: Pursuant to the Arrangement Agreement (the "Arrangement Agreement"), dated as of February 6, 2026, by and among SunOpta Inc. ("SunOpta"), Pegasus BidCo B.V. ("Parent") and 2786694 Alberta Ltd. ("Purchaser"), Purchaser acquired all of SunOpta's issued and outstanding common shares in the capital of SunOpta (the "Common Shares") by way of a court-approved statutory plan of arrangement under Section 192 of the Canada Business Corporations Act (the "Arrangement"). At the effective time of the Arrangement (the "Effective Time"), each of SunOpta's issued and outstanding Common Shares were transferred to Purchaser for consideration of $6.50 per share in cash, less applicable withholdings (the "Consideration").
• F2: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
• F3: At the Effective Time, each restricted stock unit ("RSU") held by the reporting person was surrendered in exchange for, subject to any withholding, a cash payment equal to the Consideration in respect of each Common Share underlying such RSU.
• F4: Each Performance Based Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
• F5: Represents the number of performance share units ("PSUs") held by the reporting person that was determined pursuant to the Arrangement Agreement to be entitled to Consideration in the Arrangement. At the Effective Time, each of these PSUs was surrendered in exchange for, subject to any withholding, a cash payment equal to the Consideration in respect of each Common Share underlying such PSU. Each PSU that was not entitled to Consideration in the Arrangement was cancelled without any consideration.
• F6: At the Effective Time, each stock option held by the reporting person was surrendered in exchange for, subject to any withholding, a cash payment equal to the amount (if any) by which the Consideration in respect of a Common Share underlying such stock option exceeds the exercise price of such stock option, multiplied by the number of Common Shares subject to such stock option. Each stock option with a per share exercise price greater than or equal to the Consideration was cancelled without any consideration.
• F7: The Brian W Kocher Revocable Trust UAD December 23, 2014, for which the reporting person is the co-trustee with his spouse.